Catalyst Wire Dossier Catalyst Wire Dossier

Auryzon Device

· Reconstrata, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Auryzon Device, covering 2025-01-23 to 2025-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Auryzon Devices in the Optimization of Ear and Nose Reconstruction Procedures [NA]

See pricing